China Dasheng Biotechnology Company
CDBT · OTC
12/31/2024 | 9/30/2024 | 3/31/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $2 | $2 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $1 | $1 | $1 | $1 |
| Enterprise Value | $4 | $3 | $2 | $2 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.001 | -0.003 | -0.003 |
| % Growth | -80% | 61.5% | 21.2% | – |
| Operating Cash Flow | -$0 | – | -$0 | -$0 |
| Capital Expenditures | -$0 | – | $0 | -$0 |
| Free Cash Flow | -$0 | – | -$0 | -$0 |